New HF Drug Scores in Phase III; Post-LVAD Meds; Angio-Guided Med Tx

Join our community to access additional content!

CRT Community

$0.00

Register for Meetings

“In The News” & “Cardiovascular Marketplace” Content Access

Listen to Podcasts

Watch On-Demand Content

CardioTube Access

Access to Recorded Live Broadcasts from CRTvirtual Meetings, DMV, & Cath Conference

Access Recorded Interviews

Download PPT Slide Decks

Join Now!
Already have an account? Login Now

CRT Community Premium

$650 Annually

Register for Meetings

“In The News” & “Cardiovascular Marketplace” Content Access

Listen to Podcasts

Watch On-Demand Content

CardioTube Access

Access to Recorded Live Broadcasts from CRTvirtual Meetings, DMV, & Cath Conference

Access Recorded Interviews

Download PPT Slide Decks

Complimentary subscription to electronic version of the CRM Journal

Access to CRT Meeting Registration Discounts

CRT Premium Content, including on-demand videos and presentation downloads

Join Now!
Already have an account? Login Now
News

New HF Drug Scores in Phase III; Post-LVAD Meds; Angio-Guided Med Tx

Posted: 11/20/2019
Author:
Crystal Phend, Senior Editor, MedPage Today
2019 News Articles AHA

Recent developments of interest in cardiovascular medicine

Vericiguat got cheers for its win in reducing heart failure hospitalization or cardiovascular death in the pivotal VICTORIA trial in heart failure with reduced ejection fraction, despite top-line results only for now. (Endpoints News)

Most Viewed Pages

Exercise Can Change Your Mind: Physical Activity’s CVD Benefits Linked to Stress-Related Neural Pathways

Live Case | Broadcasting from Tucson Medical Center | Tucson, AZ

Abiomed’s Updated Instructions for Certain Impella Pumps Identified as Class I Action: FDA

Live Case | Broadcasting from Tucson Medical Center | Tucson, AZ

Navitor Valve Is Safe, Effective for High- or Extreme-Surgical-Risk Patients With AS: Navitor IDE Study

Explore the Site

Stay Connected

CRT Group Foundation is a not for profit corporation dedicated to providing educational services in the field of cardiology through the website, CRTonline.org and the Cardiovascular Research Technologies (CRT) annual symposium. CRT focuses on the advances and changes in the field of cardiovascular medicine. CRT is designed to provide access to the world’s leading clinicians and the latest research in order to improve practice and treatment outcomes for a variety of health care professionals.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details

Join our community to access additional content!

CRT Community

CRT Community Premium

News

New HF Drug Scores in Phase III; Post-LVAD Meds; Angio-Guided Med Tx

Recent developments of interest in cardiovascular medicine

Most Viewed Pages

Explore the Site

Stay Connected